<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Akingbade D</submitter><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>454-61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3285145</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(2)</volume><pubmed_abstract>Oxidative stress triggers DNA and lipid peroxidation, leading to the formation of electrophiles that react with DNA to form adducts. A product of this pathway, (3-(2'-deoxy-β-d-erythro-pentofuranosyl)-pyrimido[1,2-α]purine-10(3H)-one), or M(1)dG, is mutagenic in bacterial and mammalian cells and is repaired by the nucleotide excision repair pathway. In vivo, M(1)dG is oxidized to a primary metabolite, (3-(2-deoxy-β-d-erythro-pentofuranosyl)-pyrimido[1,2-α]purine-6,10(3H,5H)-dione, or 6-oxo-M(1)dG, which is excreted in urine, bile, and feces. We have developed a specific monoclonal antibody against 6-oxo-M(1)dG and have incorporated this antibody into a procedure for the immunoaffinity isolation of 6-oxo-M(1)dG from biological matrices. The purified analyte is quantified by LC-MS/MS using a</pubmed_abstract><journal>Chemical research in toxicology</journal><pubmed_title>Selection of monoclonal antibodies against 6-oxo-M(1)dG and their use in an LC-MS/MS assay for the presence of 6-oxo-M(1)dG in vivo.</pubmed_title><pmcid>PMC3285145</pmcid><funding_grant_id>R37 CA087819</funding_grant_id><pubmed_authors>Marnett LJ</pubmed_authors><pubmed_authors>Szekely J</pubmed_authors><pubmed_authors>Akingbade D</pubmed_authors><pubmed_authors>Carnahan R</pubmed_authors><pubmed_authors>Cooper T</pubmed_authors><pubmed_authors>Kingsley PJ</pubmed_authors><pubmed_authors>Shuck SC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Selection of monoclonal antibodies against 6-oxo-M(1)dG and their use in an LC-MS/MS assay for the presence of 6-oxo-M(1)dG in vivo.</name><description>Oxidative stress triggers DNA and lipid peroxidation, leading to the formation of electrophiles that react with DNA to form adducts. A product of this pathway, (3-(2'-deoxy-β-d-erythro-pentofuranosyl)-pyrimido[1,2-α]purine-10(3H)-one), or M(1)dG, is mutagenic in bacterial and mammalian cells and is repaired by the nucleotide excision repair pathway. In vivo, M(1)dG is oxidized to a primary metabolite, (3-(2-deoxy-β-d-erythro-pentofuranosyl)-pyrimido[1,2-α]purine-6,10(3H,5H)-dione, or 6-oxo-M(1)dG, which is excreted in urine, bile, and feces. We have developed a specific monoclonal antibody against 6-oxo-M(1)dG and have incorporated this antibody into a procedure for the immunoaffinity isolation of 6-oxo-M(1)dG from biological matrices. The purified analyte is quantified by LC-MS/MS using a</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Feb</publication><modification>2025-06-01T03:32:40.065Z</modification><creation>2025-06-01T03:32:40.065Z</creation></dates><accession>S-EPMC3285145</accession><cross_references><pubmed>22211372</pubmed><doi>10.1021/tx200494h</doi></cross_references></HashMap>